153 related articles for article (PubMed ID: 17264840)
1. Selective epigenetic alteration of layer I GABAergic neurons isolated from prefrontal cortex of schizophrenia patients using laser-assisted microdissection.
Ruzicka WB; Zhubi A; Veldic M; Grayson DR; Costa E; Guidotti A
Mol Psychiatry; 2007 Apr; 12(4):385-97. PubMed ID: 17264840
[TBL] [Abstract][Full Text] [Related]
2. DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures.
Noh JS; Sharma RP; Veldic M; Salvacion AA; Jia X; Chen Y; Costa E; Guidotti A; Grayson DR
Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1749-54. PubMed ID: 15671176
[TBL] [Abstract][Full Text] [Related]
3. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1.
Veldic M; Guidotti A; Maloku E; Davis JM; Costa E
Proc Natl Acad Sci U S A; 2005 Feb; 102(6):2152-7. PubMed ID: 15684088
[TBL] [Abstract][Full Text] [Related]
4. NMDA receptor subunit expression in GABAergic interneurons in the prefrontal cortex: application of laser microdissection technique.
Xi D; Keeler B; Zhang W; Houle JD; Gao WJ
J Neurosci Methods; 2009 Jan; 176(2):172-81. PubMed ID: 18845188
[TBL] [Abstract][Full Text] [Related]
5. GABAergic mechanisms of hippocampal hyperactivity in schizophrenia.
Heckers S; Konradi C
Schizophr Res; 2015 Sep; 167(1-3):4-11. PubMed ID: 25449711
[TBL] [Abstract][Full Text] [Related]
6. Molecular etiologies of schizophrenia: are we almost there yet?
Goldman D
Am J Psychiatry; 2011 Sep; 168(9):879-81. PubMed ID: 21890799
[No Abstract] [Full Text] [Related]
7. Molecular profiles of pyramidal neurons in the superior temporal cortex in schizophrenia.
Pietersen CY; Mauney SA; Kim SS; Lim MP; Rooney RJ; Goldstein JM; Petryshen TL; Seidman LJ; Shenton ME; McCarley RW; Sonntag KC; Woo TU
J Neurogenet; 2014; 28(1-2):53-69. PubMed ID: 24702465
[TBL] [Abstract][Full Text] [Related]
8. The dynamics of DNA methylation in schizophrenia and related psychiatric disorders.
Grayson DR; Guidotti A
Neuropsychopharmacology; 2013 Jan; 38(1):138-66. PubMed ID: 22948975
[TBL] [Abstract][Full Text] [Related]
9. Reduced GABAergic neuropil and interneuron profiles in schizophrenia: Complementary analysis of disease course-related differences.
Förster A; Model V; Gos T; Frodl T; Schiltz K; Dobrowolny H; Meyer-Lotz G; Guest PC; Mawrin C; Bernstein HG; Bogerts B; Schlaaff K; Steiner J
J Psychiatr Res; 2021 Nov; 145():50-59. PubMed ID: 34864489
[TBL] [Abstract][Full Text] [Related]
10. Aging reduces total neuron number in the dorsal component of the rodent prefrontal cortex.
Stranahan AM; Jiam NT; Spiegel AM; Gallagher M
J Comp Neurol; 2012 Apr; 520(6):1318-26. PubMed ID: 22020730
[TBL] [Abstract][Full Text] [Related]
11. Scaling of smaller pyramidal neuron size and lower energy production in schizophrenia.
Schoonover KE; Miller NE; Fish KN; Lewis DA
Neurobiol Dis; 2024 Feb; 191():106394. PubMed ID: 38176569
[TBL] [Abstract][Full Text] [Related]
12. Genetic Implication of Prenatal GABAergic and Cholinergic Neuron Development in Susceptibility to Schizophrenia.
Cameron D; Vinh NN; Prapaiwongs P; Perry EA; Walters JTR; Li M; O'Donovan MC; Bray NJ
Schizophr Bull; 2024 Jun; ():. PubMed ID: 38869145
[TBL] [Abstract][Full Text] [Related]
13. Genetic implication of prenatal GABAergic and cholinergic neuron development in susceptibility to schizophrenia.
Cameron D; Vinh NN; Prapaiwongs P; Perry EA; Walters JTR; Li M; O'Donovan MC; Bray NJ
medRxiv; 2023 Dec; ():. PubMed ID: 38168283
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation of cell death machinery in the prefrontal cortex of human alcoholics.
Johansson S; Ekström TJ; Marinova Z; Okvist A; Sheedy D; Garrick T; Harper C; Kuzmin A; Yakovleva T; Bakalkin G
Int J Neuropsychopharmacol; 2009 Feb; 12(1):109-15. PubMed ID: 18937880
[TBL] [Abstract][Full Text] [Related]
15. Genetic identification of brain cell types underlying schizophrenia.
Skene NG; Bryois J; Bakken TE; Breen G; Crowley JJ; Gaspar HA; Giusti-Rodriguez P; Hodge RD; Miller JA; Muñoz-Manchado AB; O'Donovan MC; Owen MJ; Pardiñas AF; Ryge J; Walters JTR; Linnarsson S; Lein ES; ; Sullivan PF; Hjerling-Leffler J
Nat Genet; 2018 Jun; 50(6):825-833. PubMed ID: 29785013
[TBL] [Abstract][Full Text] [Related]
16. GABAergic System Dysfunction and Challenges in Schizophrenia Research.
Jahangir M; Zhou JS; Lang B; Wang XP
Front Cell Dev Biol; 2021; 9():663854. PubMed ID: 34055795
[TBL] [Abstract][Full Text] [Related]
17. SAVAs: Molecular Snipers for Silencing GABAergic Interneurons.
Naegele JR
Epilepsy Curr; 2012 Nov; 12(6):216-7. PubMed ID: 23447714
[No Abstract] [Full Text] [Related]
18. Reelin Signaling and Synaptic Plasticity in Schizophrenia.
Markiewicz R; Markiewicz-Gospodarek A; Borowski B; Trubalski M; Łoza B
Brain Sci; 2023 Dec; 13(12):. PubMed ID: 38137152
[TBL] [Abstract][Full Text] [Related]
19. DNA methylation and the opposing NMDAR dysfunction in schizophrenia and major depression disorders: a converging model for the therapeutic effects of psychedelic compounds in the treatment of psychiatric illness.
Flynn LT; Gao WJ
Mol Psychiatry; 2023 Nov; 28(11):4553-4567. PubMed ID: 37679470
[TBL] [Abstract][Full Text] [Related]
20. Understanding the mechanism of action and clinical effects of neuroactive steroids and GABAergic compounds in major depressive disorder.
Cutler AJ; Mattingly GW; Maletic V
Transl Psychiatry; 2023 Jun; 13(1):228. PubMed ID: 37365161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
